Provided by Tiger Trade Technology Pte. Ltd.

Ascendis Pharma A/S

263.59
+2.360.90%
Volume:187.06K
Turnover:49.16M
Market Cap:17.45B
PE:20.34
High:266.34
Open:263.34
Low:259.48
Close:261.23
52wk High:282.15
52wk Low:186.05
Shares:66.19M
Float Shares:65.54M
Volume Ratio:0.37
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):12.96
EPS(LYR):-4.4176
ROE:118.78%
ROA:9.58%
PB:10.47
PE(LYR):-59.67

Loading ...

Earnings Flash (ASND) Ascendis Pharma Posts Q2 Non-IFRS EPS 0.90 Euros, vs. FactSet Est of 1.80 Euros

MT Newswires Live
·
Aug 13

Ascendis Pharma Q2 Revenue EUR 339.3 Million

THOMSON REUTERS
·
Aug 13

Ascendis Pharma Q2 FY26 Swings to Net Profit of €207 Million; Revenue More than Doubles to €339 Million

Reuters
·
Aug 13

Ascendis Pharma Q2 Adj. EPS $1.05 Beats $0.78 Estimate, Sales $394.437M Beat $353.800M Estimate

Benzinga Earnings
·
Aug 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 13

Ascendis Pharma A/S Expected to Post Earnings of €1.38 a Share - Earnings Preview

Reuters
·
Aug 11

Cantor Fitzgerald Reaffirms Their Buy Rating on Ascendis Pharma (ASND)

TIPRANKS
·
Aug 08

Analysts Offer Insights on Healthcare Companies: Progyny (PGNY), Scholar Rock Holding (SRRK) and Ascendis Pharma (ASND)

TIPRANKS
·
Aug 08

Ascendis Pharma Updates Financial Calendar Ahead of Quarterly Results Release and Webcast

Reuters
·
Aug 07

Ascendis Pharma Seeing 'Good Progress' in Achondroplasia Programs, Wedbush Says

MT Newswires Live
·
Aug 07

European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading

MT Newswires Live
·
Aug 06

Ascendis Pharma Posts Slide Presentation on Achondroplasia Program Updates

Reuters
·
Aug 06

Ascendis Announces Coach Week 78 Results and Provides Update on Achondroplasia Programs and Yuviwel® Uptake in the U.S.

THOMSON REUTERS
·
Aug 06

Ascendis Pharma a/S - Safety and Tolerability Remain Consistent for Monotherapy and Combination Therapy

THOMSON REUTERS
·
Aug 06

European Equities Traded in US as ADRs Advance in Tuesday Trading

MT Newswires Live
·
Aug 04

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Moderna (MRNA) and Stevanato Group (STVN)

TIPRANKS
·
Aug 03

Ascendis Pharma A/S Expected to Post Earnings of €1.38 a Share - Earnings Preview

Reuters
·
Aug 03

Ascendis Pharma is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 24

Ascendis Pharma (ASND) Says 104 Week TransCon CNP Data Still Looks Strong

Simply Wall St.
·
Jul 12

Ascendis Pharma Stock's Strong Momentum to Continue, Wedbush Says

MT Newswires Live
·
Jul 09